Acellus Biotech helps international life-science companies establish and grow their commercial presence in the United States through technical sales, business development, market strategy, and relationship-driven account growth.
Rooted in science. Driven by relationships.
Your technology is ready for a bigger market. Your organization may not be. Acellus bridges that gap as your outsourced U.S. business-development and commercial lead.
We establish the relationships, pipeline, and processes that support growth—then help you build the permanent team to carry it forward.
Meet AcellusStart with the commercial support you need.
Move toward the organization you own.
Establish a focused market position, identify target accounts, develop outreach, and manage strategic opportunities.
Turn early traction into a permanent commercial organization with the right people, structure, and operating rhythm.
Keep experienced fractional leadership in place while your team ramps, then transfer the commercial system to you.
Explore how an engagement can take shape.
Scope and deliverables are agreed together.
A focused start for companies with a strong offering and limited local commercial coverage.
Explore this engagementAccount intelligence, relationship history, opportunity context, and a repeatable commercial process.
Specialized technologies need a partner who can understand the science and connect it to the market.
Explore our capabilitiesEstablish a focused U.S. presence without immediately hiring a full local sales organization.
Create account strategy, pipeline, and commercial processes that support your next phase.
Connect strong scientific capabilities to a disciplined, repeatable approach to sales.
M.S. · Molecular Biology
Based in South Carolina, serving U.S. accounts nationwide.
Morgan brings more than a decade of experience across life-science business development, laboratory science, and education. That combination informs an approach built around understanding the technology, earning the buyer’s confidence, and following through commercially.
I've spent my career on both sides of the bench, and I love helping strong science find the people who need it.
Previous commercial roles at Infinity Bio, Synbio Technologies, Abiosciences, GenScript, and Evotec span molecular diagnostics, gene and oligonucleotide synthesis, peptides, proteins, antibodies, and genomics.
Organizations listed describe Morgan’s prior experience; they are not presented as Acellus clients or endorsers.
Explore Morgan’s backgroundFor biotech startup founders and scientists around the world: practical coaching to clarify your value, strengthen customer conversations, and plan your next commercial steps.
A focused starting engagement to establish priorities,
activate outreach, and build an operating rhythm.
Assess the offering, clarify U.S. buyer segments, prioritize target accounts, and shape the commercial message.
Market-entry brief and target-account prioritiesBegin focused outreach, develop early conversations, qualify needs, and use market feedback to refine the approach.
Outreach activity and opportunity contextReview the developing pipeline, document the process, and identify the coverage and team needs for the next stage.
Commercial review and next-stage roadmapWe define the scope together before work starts.
The sequence adapts to your technology and market.
Understand your offering, existing customers, commercial activity, and U.S. growth priorities.
A shared view of the opportunity.Agree on the initial account focus, engagement scope, responsibilities, and measures of progress.
A focused commercial plan.Put outreach, opportunity management, and a consistent review rhythm into motion.
An operating process with visible next steps.No. Acellus can begin as your outsourced U.S. commercial lead, helping establish target accounts, outreach, pipeline discipline, and sales processes before you build a permanent team.
Yes. The starting point depends on your current market presence and priorities. An engagement may focus on market entry, business development, team buildout, or fractional leadership. Scope is agreed before work begins.
The first conversation can focus on non-confidential capabilities, buyer segments, and commercial goals. Confidential technical details and appropriate information-sharing arrangements can be addressed separately.
The engagement is designed around eventual client ownership. Processes, account context, opportunity information, and team responsibilities are documented and transferred as part of the agreed handoff.
Timing and fees depend on the scope, technical offering, market priorities, and level of commercial support required. These are discussed during discovery and defined in an engagement proposal.
Tell us about your technology, your ambitions,
and where you are today.
